CA1208516A - Methodes et appareils pour supprimer les constrictions arterielles - Google Patents

Methodes et appareils pour supprimer les constrictions arterielles

Info

Publication number: CA1208516A
Authority: CA; Canada
Prior art keywords: plaque; solution; catheter; chamber; solubilizing
Prior art date: 1982-04-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000425089A

Other languages

English (en)

Inventor

Harvey Wolinsky

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-04-02

Filing date

1983-03-31

Publication date

1986-07-29

1983-03-31 Application filed by Individual filed Critical Individual

1986-07-29 Application granted granted Critical

1986-07-29 Publication of CA1208516A publication Critical patent/CA1208516A/fr

Status Expired legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims description 25
230000003381 solubilizing effect Effects 0.000 claims abstract description 31
239000003613 bile acid Substances 0.000 claims description 15
150000003904 phospholipids Chemical class 0.000 claims description 14
HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 claims description 13
210000001367 artery Anatomy 0.000 claims description 12
102000029816 Collagenase Human genes 0.000 claims description 10
108060005980 Collagenase Proteins 0.000 claims description 10
229960002424 collagenase Drugs 0.000 claims description 10
239000012530 fluid Substances 0.000 claims description 9
239000000787 lecithin Substances 0.000 claims description 5
235000010445 lecithin Nutrition 0.000 claims description 5
239000000203 mixture Substances 0.000 claims description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
239000007787 solid Substances 0.000 claims description 4
238000003780 insertion Methods 0.000 claims description 3
230000037431 insertion Effects 0.000 claims description 3
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 3
239000002253 acid Substances 0.000 claims 3
150000007513 acids Chemical class 0.000 claims 3
229940067606 lecithin Drugs 0.000 claims 3
201000001320 Atherosclerosis Diseases 0.000 claims 1
239000007788 liquid Substances 0.000 abstract description 14
229940067631 phospholipid Drugs 0.000 description 7
210000004027 cell Anatomy 0.000 description 4
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
239000000243 solution Substances 0.000 description 4
238000012384 transportation and delivery Methods 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
239000004365 Protease Substances 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
230000003902 lesion Effects 0.000 description 3
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
208000037260 Atherosclerotic Plaque Diseases 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
102000008186 Collagen Human genes 0.000 description 2
108010035532 Collagen Proteins 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
239000012062 aqueous buffer Substances 0.000 description 2
239000000872 buffer Substances 0.000 description 2
239000008366 buffered solution Substances 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
239000011575 calcium Substances 0.000 description 2
235000012000 cholesterol Nutrition 0.000 description 2
229920001436 collagen Polymers 0.000 description 2
KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
239000008344 egg yolk phospholipid Substances 0.000 description 2
239000000463 material Substances 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
-1 polyethylene Polymers 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
230000002966 stenotic effect Effects 0.000 description 2
BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 1
LRYZPFWEZHSTHD-HEFFAWAOSA-O 2-[[(e,2s,3r)-2-formamido-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium Chemical class CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](NC=O)COP(O)(=O)OCC[N+](C)(C)C LRYZPFWEZHSTHD-HEFFAWAOSA-O 0.000 description 1
ADHFMENDOUEJRK-UHFFFAOYSA-N 9-[(4-fluorophenyl)methyl]-n-hydroxypyrido[3,4-b]indole-3-carboxamide Chemical compound C1=NC(C(=O)NO)=CC(C2=CC=CC=C22)=C1N2CC1=CC=C(F)C=C1 ADHFMENDOUEJRK-UHFFFAOYSA-N 0.000 description 1
206010060965 Arterial stenosis Diseases 0.000 description 1
206010003210 Arteriosclerosis Diseases 0.000 description 1
101100481176 Bacillus subtilis (strain 168) thiE gene Proteins 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
102000011413 Chondroitinases and Chondroitin Lyases Human genes 0.000 description 1
108010023736 Chondroitinases and Chondroitin Lyases Proteins 0.000 description 1
108090000317 Chymotrypsin Proteins 0.000 description 1
206010053567 Coagulopathies Diseases 0.000 description 1
208000034423 Delivery Diseases 0.000 description 1
101100494344 Desulfobacterium autotrophicum (strain ATCC 43914 / DSM 3382 / HRM2) bzaF gene Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
206010015866 Extravasation Diseases 0.000 description 1
108010003272 Hyaluronate lyase Proteins 0.000 description 1
102000009066 Hyaluronoglucosaminidase Human genes 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
SMEROWZSTRWXGI-UHFFFAOYSA-N Lithocholsaeure Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 SMEROWZSTRWXGI-UHFFFAOYSA-N 0.000 description 1
RFDAIACWWDREDC-UHFFFAOYSA-N Na salt-Glycocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)C(O)C2 RFDAIACWWDREDC-UHFFFAOYSA-N 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
208000031481 Pathologic Constriction Diseases 0.000 description 1
241001482237 Pica Species 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
229920001328 Polyvinylidene chloride Polymers 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
WBWWGRHZICKQGZ-UHFFFAOYSA-N Taurocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)C(O)C2 WBWWGRHZICKQGZ-UHFFFAOYSA-N 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
210000001789 adipocyte Anatomy 0.000 description 1
230000004075 alteration Effects 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
238000013459 approach Methods 0.000 description 1
SCJNCDSAIRBRIA-DOFZRALJSA-N arachidonyl-2'-chloroethylamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCCl SCJNCDSAIRBRIA-DOFZRALJSA-N 0.000 description 1
230000003143 atherosclerotic effect Effects 0.000 description 1
230000003190 augmentative effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 1
150000001840 cholesterol esters Chemical class 0.000 description 1
BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
239000002812 cholic acid derivative Substances 0.000 description 1
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
229960001231 choline Drugs 0.000 description 1
229960002376 chymotrypsin Drugs 0.000 description 1
230000035602 clotting Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
208000029078 coronary artery disease Diseases 0.000 description 1
210000004351 coronary vessel Anatomy 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
230000008021 deposition Effects 0.000 description 1
CEJLBZWIKQJOAT-UHFFFAOYSA-N dichloroisocyanuric acid Chemical compound ClN1C(=O)NC(=O)N(Cl)C1=O CEJLBZWIKQJOAT-UHFFFAOYSA-N 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000002297 emergency surgery Methods 0.000 description 1
229940088598 enzyme Drugs 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
230000036251 extravasation Effects 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
210000001105 femoral artery Anatomy 0.000 description 1
RFDAIACWWDREDC-FRVQLJSFSA-N glycocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 RFDAIACWWDREDC-FRVQLJSFSA-N 0.000 description 1
230000002008 hemorrhagic effect Effects 0.000 description 1
229960002773 hyaluronidase Drugs 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000006872 improvement Effects 0.000 description 1
239000000543 intermediate Substances 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
SMEROWZSTRWXGI-HVATVPOCSA-N lithocholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 SMEROWZSTRWXGI-HVATVPOCSA-N 0.000 description 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
229940055729 papain Drugs 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
239000002953 phosphate buffered saline Substances 0.000 description 1
239000003495 polar organic solvent Substances 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920000098 polyolefin Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920000915 polyvinyl chloride Polymers 0.000 description 1
239000004800 polyvinyl chloride Substances 0.000 description 1
229920001291 polyvinyl halide Polymers 0.000 description 1
239000005033 polyvinylidene chloride Substances 0.000 description 1
208000037803 restenosis Diseases 0.000 description 1
239000000523 sample Substances 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
239000002904 solvent Substances 0.000 description 1
208000037804 stenosis Diseases 0.000 description 1
230000036262 stenosis Effects 0.000 description 1
230000003319 supportive effect Effects 0.000 description 1
239000002344 surface layer Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
WBWWGRHZICKQGZ-GIHLXUJPSA-N taurocholic acid Chemical compound C([C@@H]1C[C@H]2O)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@H](O)C1 WBWWGRHZICKQGZ-GIHLXUJPSA-N 0.000 description 1
101150029215 thiC gene Proteins 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
210000002385 vertebral artery Anatomy 0.000 description 1
238000012800 visualization Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/041—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0108—Steering means as part of the catheter or advancing means; Markers for positioning using radio-opaque or ultrasound markers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/104—Balloon catheters used for angioplasty
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22038—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with a guide wire
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22055—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation with three or more balloons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22062—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation to be filled with liquid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22082—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
- A61B2017/22084—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance stone- or thrombus-dissolving
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Biophysics (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Surgery (AREA)
Anesthesiology (AREA)
Medical Informatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Child & Adolescent Psychology (AREA)
Media Introduction/Drainage Providing Device (AREA)
Medicinal Preparation (AREA)

CA000425089A 1982-04-02 1983-03-31 Methodes et appareils pour supprimer les constrictions arterielles Expired CA1208516A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US36490882A	1982-04-02	1982-04-02
US364,908		1982-04-02

Publications (1)

Publication Number	Publication Date
CA1208516A true CA1208516A (fr)	1986-07-29

Family

ID=23436623

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000425089A Expired CA1208516A (fr)	1982-04-02	1983-03-31	Methodes et appareils pour supprimer les constrictions arterielles

Country Status (6)

Country	Link
EP (1)	EP0105350A4 (fr)
JP (1)	JPS59500504A (fr)
CA (1)	CA1208516A (fr)
IT (1)	IT1167171B (fr)
MX (1)	MX160113A (fr)
WO (1)	WO1983003356A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2577410B1 (fr) *	1985-02-20	1989-04-28	Gilles Karcher	Sonde endoscopique a laser
US7238673B2 (en)	1989-03-31	2007-07-03	The Regents Of The University Of Michigan	Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
DE3915289A1 (de) *	1989-05-10	1990-11-15	Josef Dieter Dr Med Nagel	Vierlumige doppel-ballonsonde
AU6376190A (en) *	1989-10-25	1991-05-02	C.R. Bard Inc.	Occluding catheter and methods for treating cerebral arteries
EP0518940A4 (en) *	1990-02-26	1993-05-12	Marvin J. Slepian	Method and apparatus for treatment of tubular organs
US5135484A (en) *	1990-05-09	1992-08-04	Pioneering Technologies, Inc.	Method of removing plaque from vessels
US5270047A (en) *	1991-11-21	1993-12-14	Kauffman Raymond F	Local delivery of dipyridamole for the treatment of proliferative diseases
HK1041659A1 (en) *	1999-02-10	2002-07-19	太田富雄	Cancer therapeutic agent supply device
EP1157709B1 (fr)	1999-02-10	2012-05-30	Tomio Ohta	Dispositif de traitement sans perfusion
BRPI0704785A2 (pt) *	2007-12-17	2018-04-10	Brz Biotecnologia Ltda.	Cateter para infusão local de fármacos

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US550238A (en) *		1895-11-26		Horace russel allen
US2499045A (en) *	1948-08-16	1950-02-28	Walker Frank Ray	Rectal dilator and medicator
US3504662A (en) *	1967-05-16	1970-04-07	Avco Corp	Intra-arterial blood pump
US3850176A (en) *	1972-02-07	1974-11-26	G Gottschalk	Nasal tampon
US3962420A (en) *	1974-07-03	1976-06-08	Rohm And Haas Company	Dissolution of gallstones
US3923065A (en) *	1974-09-09	1975-12-02	Jerome Nozick	Embolectomy catheter
US4115313A (en) *	1974-10-08	1978-09-19	Irving Lyon	Bile acid emulsions
FR2351634A1 (fr) *	1976-05-18	1977-12-16	Leroyer Guy	Sonde urinaire a diametre variable
US4320121A (en) *	1976-10-12	1982-03-16	Sears Barry D	Method of emulsifying cholesterol, cholesterol esters and triglyceride compounds
JPS5431985A (en) *	1977-08-15	1979-03-09	Izumi Amano	Blood vessel double balloon catheter
US4299226A (en) *	1979-08-08	1981-11-10	Banka Vidya S	Coronary dilation method
US4338300A (en) *	1981-02-05	1982-07-06	The Regents Of The University Of California	Use of purified clostridial collangenase in the treatment of Peyronie's disease

1983
- 1983-03-31 CA CA000425089A patent/CA1208516A/fr not_active Expired
- 1983-04-01 JP JP58501763A patent/JPS59500504A/ja active Pending
- 1983-04-01 WO PCT/US1983/000454 patent/WO1983003356A1/fr not_active Ceased
- 1983-04-01 IT IT20442/83A patent/IT1167171B/it active
- 1983-04-01 EP EP19830901648 patent/EP0105350A4/fr not_active Withdrawn
- 1983-04-04 MX MX196820A patent/MX160113A/es unknown

Also Published As

Publication number	Publication date
IT8320442A0 (it)	1983-04-01
EP0105350A1 (fr)	1984-04-18
MX160113A (es)	1989-11-30
JPS59500504A (ja)	1984-03-29
IT1167171B (it)	1987-05-13
EP0105350A4 (fr)	1987-10-26
WO1983003356A1 (fr)	1983-10-13

Legal Events

Date	Code	Title	Description
2003-07-29	MKEX	Expiry

Publication	Publication Date	Title
US4636195A (en)	1987-01-13	Method and apparatus for removing arterial constriction
US4824436A (en)	1989-04-25	Method for the prevention of restenosis
US4705517A (en)	1987-11-10	Percutaneously deliverable intravascular occlusion prosthesis
EP0478600B1 (fr)	1999-11-10	Ameliorations du flux sanguin
US4923464A (en)	1990-05-08	Percutaneously deliverable intravascular reconstruction prosthesis
US5674198A (en)	1997-10-07	Tandem balloon catheter
US5599307A (en)	1997-02-04	Catheter and method for the prevention and/or treatment of stenotic processes of vessels and cavities
CA1208516A (fr)	1986-07-29	Methodes et appareils pour supprimer les constrictions arterielles
US4929602A (en)	1990-05-29	Method of inhibiting platelet dependent arterial thrombosis
US20010029349A1 (en)	2001-10-11	Method and apparatus for treating aneurysms
EP2241271A1 (fr)	2010-10-20	Procédés et dispositifs de réduction du contenu en minéraux des lésions vasculaires calcifiées
EP0983027B1 (fr)	2005-12-28	Dispositif destine a obstruer partiellement des vaisseaux sanguins
WO1995011719A1 (fr)	1995-05-04	Traitement d'obstructions dans des passages du corps humain
JPH03505411A (ja)	1991-11-28	拡張カテーテル
JPH0522551B2 (fr)	1993-03-29
Penha et al.	1988	Morphodynamic interpretation of acute coronary thrombosis, with special reference to volcano-like eruption of atheromatous plaque caused by coronary artery spasm
EP0220236B1 (fr)	1994-03-02	Methode de prevention de la restenosis
Uchida et al.	1986	Fiberoptic observation of thrombosis and thrombolysis in isolated human coronary arteries
CHAVEZ	1976	False aneurysms of the femoral artery: a challenge in management
Walker et al.	1978	Relationship of the constituents of bile to biliary peritonitis in the rat.
Waller et al.	1984	Morphologic observations in coronary arteries, aortocoronary saphenous vein bypass grafts, and infant aortae following balloon angioplasty procedures
Savage	2012	Problems in peripheral vascular disease
RU2086186C1 (ru)	1997-08-10	Способ лечения острого холецистита
Nankin et al.	1972	Use of Fogarty catheter for removal of inspissated meconium
O’Connell et al.	1950	Coarctation of the aorta: A new technique